Paul Boyer Email & Phone Number

Cary, Nc, Us

Provided fractional C-suite services to high-tech companies, including M&A advisory, fundraising, scale, and operations management. Served industries including Renewable/Cleantech/Energy Transition, SaaS, Biotech, Pharma, MedTech, AgTech, and Insurtech.✪ DELIVERED RESULTS:• Interim CFO to VC/PE backed company in the Energy Transition & Additive industries. Helped manage recapitalization into a single Series E, with a $40M new cash investment for the buildout of a pilot manufacturing facility for US based, IRA compliant battery cathode (NMC/LFP), and expansion of Additive production.• Hired to lead merger and launch a new patented Insurtech alongside 2 co-founders as fractional CFO, charting growth from zero to ~$395M in 5 years. Raised $28M in debt to buy out an investor and $25M from 2 industry veterans in the only equity round. Scaled to 185 staff and built out systems, processes, controls, models, budgets, and more.• Supported the spin-out of a $56M AgTech joint venture with a long-term vision for the space on a newly formed leadership team; developed strategy, implemented systems and budgets, led build-out of new office and lab facilities, HR, IT, legal, and facilities, and established the entrepreneurial operating systems.

Durham, North Carolina, Us

Hired full-time as CEO’s right-hand to spin out a food ingredients subsidiary from a larger publicly traded business after a successful spell as a consultant to the company. Built out the standalone’s entire financial and operational infrastructure for next-generation ingredient company reimagining the future of food and empowering people to live healthy lives.✪ DELIVERED RESULTS:• Raised $45M Series A financing from world-class investors to fund team hiring and company scale across all functions.• Seamlessly set up R&D, HR, IT, legal, and other business functions within 3 months for a start-up, taking advantage of its parent company’s highly advanced proprietary gene-editing platform.• Defined long-term strategy to transform from an R&D services company to a product-focused company, developing a 10-year financial model to support business case demonstrating COGS would result in profitability within investor timeline.• Helped drive the fast-paced transition to a products company, identifying sugar alternatives as an initial use case for the platform.

Durham, Nc, Us

Recruited to oversee strategic direction across accounting, finance, IT, HR, legal, purchasing, investor relations, and business administration as the company navigated toward its first product approval in a cutting-edge Biotech space.✪ DELIVERED RESULTS:• Raised ~$437M in equity funding from a global consortium of investors, including family offices, alternative funds, and ultra-high-net-worth individuals. Secured ~$40M in non-dilutive funding from National Institutes of Health, Department of Defense, and California Institute for Regenerative Medicine.• Negotiated strategic global distribution and supply agreement with Fresenius Medical Care for the first product indication in the renal care (dialysis access) category, which included a $150M equity investment.• Oversaw all financial aspects of the build-out of the first-ever, state-of-the-art $50M bioprocessing facility.• Scaled headcount from 13 to 130+, overseeing HR with a focus on strong culture and organizational development.

Built and delivered a market-leading C-suite team for a range of early-stage companies after identifying an opportunity to provide start-ups in the region with high-impact M&A advisory, fundraising, and turnaround management expertise. Served growth companies in SaaS, cloud, Cleantech, AgTech, Insurtech, Biotech, healthcare, and solar.✪ DELIVERED RESULTS:• Landed 23 clients in less than 5 years, growing the business 25%+ YoY, and increasing revenue from zero to ~$2M.• Named Top 50 Entrepreneur for 2012 by Business Leader Magazine, won CFO of the Year 2009 for Best Turnaround Company by Triangle Business Journal, and cited in 2 Forbes profiles (2012 and 2013) as Best in Business.• Completed 2 sell-side M&A transactions (for Intersouth Partners and Square 1 Bank) and 2 buy-side and 2 sell-side M&A projects for 4 additional clients. Raised $63M+ in debt and equity securities for clients.

Us

Recruited to turn around an underperforming, high-potential privately held start-up venture backed by Paladin Capital and Emerald Technology Ventures to provide natural, antimicrobial solutions. Positioned the company for sale by evaluating strong technology synergies, rationalized markets, and verticals to identify the highest-momentum revenue and built a robust budget process.

Appointed to the newly formed executive team of a privately held, venture-backed, thin-film lithium polymer battery technology and manufacturing start-up to revamp business strategy for the transition from early-stage to capacity for product commercialization and scalable manufacturing operations. Oversaw CFO duties, M&A, HR, legal, IP, and IT. Conducted extensive market development and analysis and delivered board presentations.